Skip to main content

Sandercock Brett

In the past year, 7 open-market sale filings worth $2.79M and no purchases.

Current role at each company

Open-market trades in the past year

Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.

Bought
–
0 filings
Sold
$2.79M
7 filings
Net
−$2.79M
Bought minus sold
Companies
1
With open-market trades

Trades

Every Form 4 that lists Sandercock Brett as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Jul 13, 2021 (view filing)Jul 121 daySandercock BrettChief Financial OfficerSSaleResMed Common Stock−2.50K$248.46−$621.1K−2.8%87.5K after
Aug 11, 2021 (view filing)Aug 101 daySandercock BrettChief Financial OfficerSSaleResMed Common Stock−2.50K$278.05−$695.1K−2.9%85.0K after
Aug 23, 2021 (view filing)Aug 203 daysSandercock BrettChief Financial OfficerSSaleResMed Common Stock−10.7K$281.73−$3.02M−10.7%89.8K after
Sep 13, 2021 (view filing)Sep 103 daysSandercock BrettChief Financial OfficerSSaleResMed Common Stock−5.00K$297.33−$1.49M−5.4%87.3K after
Oct 12, 2021 (view filing)Oct 111 daySandercock BrettChief Financial OfficerSSaleResMed Common Stock−5.00K$253.37−$1.27M−5.6%84.8K after
Nov 12, 2021 (view filing)Nov 102 daysSandercock BrettChief Financial OfficerSSaleResMed Common Stock−2.50K$260.58−$651.5K−2.9%84.8K after
Dec 14, 2021 (view filing)Dec 104 daysSandercock BrettChief Financial OfficerSSaleResMed Common Stock−2.50K$264.92−$662.3K−2.3%106.4K after
Jan 11, 2022 (view filing)Jan 101 daySandercock BrettChief Financial OfficerSSaleResMed Common Stock−2.50K$235.00−$587.5K−2.3%106.4K after
Feb 14, 2022 (view filing)Feb 104 daysSandercock BrettChief Financial OfficerSSaleResMed Common Stock−2.50K$241.86−$604.6K−2.3%106.4K after
Mar 14, 2022 (view filing)Mar 104 daysSandercock BrettChief Financial OfficerSSaleResMed Common Stock−2.50K$241.29−$603.2K−2.3%106.4K after
Apr 12, 2022 (view filing)Apr 111 daySandercock BrettChief Financial OfficerSSaleResMed Common Stock−2.50K$247.00−$617.5K−2.3%106.4K after
Jul 26, 2022 (view filing)Jul 224 daysSandercock BrettChief Financial OfficerSSaleResMed Common Stock−7.50K$235.00−$1.76M−6.6%106.4K after
Aug 12, 2022 (view filing)Aug 102 daysSandercock BrettChief Financial OfficerSSaleResMed Common Stock−2.50K$240.66−$601.6K−2.3%106.4K after
Nov 9, 2022 (view filing)Nov 72 daysSandercock BrettChief Financial OfficerSSaleResMed Common Stock−4.00K$212.02−$848.1K−3.6%106.3K after
Feb 14, 2023 (view filing)Feb 131 daySandercock BrettChief Financial OfficerSSaleResMed Common Stock−4.00K$215.00−$860.0K−3.3%116.9K after
Feb 22, 2023 (view filing)Feb 175 daysSandercock BrettChief Financial OfficerSSaleResMed Common Stock−10.0K$215.22−$2.15M−8.6%106.9K after
May 10, 2023 (view filing)May 91 daySandercock BrettChief Financial OfficerSSaleResMed Common Stock−3.43K$232.05−$795.0K−3.2%103.5K after
May 12, 2023 (view filing)May 102 daysSandercock BrettChief Financial OfficerSSaleResMed Common Stock−12.6K$233.13−$2.93M−12.1%90.9K after
Nov 29, 2023 (view filing)Nov 272 daysSandercock BrettChief Financial OfficerSSaleResMed Common Stock−3.00K$152.62−$457.9K−3.1%93.0K after
May 10, 2024 (view filing)May 82 daysSandercock BrettChief Financial OfficerSSaleResMed Common Stock−13.0K$211.37−$2.75M−12.4%92.1K after10b5-1
Jun 11, 2024 (view filing)Jun 101 daySandercock BrettChief Financial OfficerSSaleResMed Common Stock−1.00K$209.81−$209.8K−1.1%91.1K after10b5-1
Jul 9, 2024 (view filing)Jul 81 daySandercock BrettChief Financial OfficerSSaleResMed Common Stock−1.00K$194.35−$194.3K−1.1%90.1K after10b5-1
Aug 12, 2024 (view filing)Aug 84 daysSandercock BrettChief Financial OfficerSSaleResMed Common Stock−1.00K$212.16−$212.2K−1.1%89.1K after10b5-1
Sep 10, 2024 (view filing)Sep 91 daySandercock BrettChief Financial OfficerSSaleResMed Common Stock−1.00K$246.42−$246.4K−1.0%96.8K after10b5-1
Oct 9, 2024 (view filing)Oct 81 daySandercock BrettChief Financial OfficerSSaleResMed Common Stock−1.00K$233.47−$233.5K−1.0%95.8K after10b5-1
Nov 12, 2024 (view filing)Nov 84 daysSandercock BrettChief Financial OfficerSSaleResMed Common Stock−1.00K$249.00−$249.0K−1.0%94.9K after10b5-1
Dec 11, 2024 (view filing)Dec 92 daysSandercock BrettChief Financial OfficerSSaleResMed Common Stock−1.00K$244.23−$244.2K−1.1%93.9K after10b5-1
Jan 10, 2025 (view filing)Jan 82 daysSandercock BrettChief Financial OfficerSSaleResMed Common Stock−1.00K$234.04−$234.0K−1.1%92.9K after10b5-1
Feb 11, 2025 (view filing)Feb 101 daySandercock BrettChief Financial OfficerSSaleResMed Common Stock−1.00K$238.98−$239.0K−1.1%91.9K after10b5-1
Mar 11, 2025 (view filing)Mar 101 daySandercock BrettChief Financial OfficerSSaleResMed Common Stock−1.00K$230.36−$230.4K−1.1%90.9K after10b5-1
Apr 10, 2025 (view filing)Apr 82 daysSandercock BrettChief Financial OfficerSSaleResMed Common Stock−1.00K$215.58−$215.6K−1.1%89.9K after10b5-1
May 27, 2025 (view filing)May 225 daysSandercock BrettChief Financial OfficerSSaleResMed Common Stock−3.64K$244.59−$891.3K−4.1%86.3K after10b5-1
Jun 3, 2025 (view filing)Jun 21 daySandercock BrettChief Financial OfficerSSaleResMed Common Stock−1.00K$243.78−$243.8K−1.2%85.3K after10b5-1
Jul 2, 2025 (view filing)Jul 11 daySandercock BrettChief Financial OfficerSSaleResMed Common Stock−3.88K$256.99−$997.9K−4.4%84.3K after10b5-1
Aug 5, 2025 (view filing)Aug 14 daysSandercock BrettChief Financial OfficerSSaleResMed Common Stock−3.00K$281.90−$845.7K−3.5%83.3K after10b5-1
Sep 3, 2025 (view filing)Sep 21 daySandercock BrettChief Financial OfficerSSaleResMed Common Stock−3.00K$270.77−$812.3K−3.3%87.7K after10b5-1
Oct 3, 2025 (view filing)Oct 12 daysSandercock BrettChief Financial OfficerSSaleResMed Common Stock−3.00K$274.36−$823.1K−3.3%86.7K after10b5-1
Nov 4, 2025 (view filing)Nov 31 daySandercock BrettChief Financial OfficerSSaleResMed Common Stock−3.00K$247.54−$742.6K−3.4%85.7K after10b5-1
Dec 2, 2025 (view filing)Dec 11 daySandercock BrettChief Financial OfficerSSaleResMed Common Stock−1.00K$244.16−$244.2K−1.1%87.5K after10b5-1
Jan 5, 2026 (view filing)Jan 23 daysSandercock BrettChief Financial OfficerSSaleResMed Common Stock−1.00K$241.75−$241.8K−1.1%86.5K after10b5-1
Feb 3, 2026 (view filing)Feb 21 daySandercock BrettChief Financial OfficerSSaleResMed Common Stock−1.00K$257.03−$257.0K−1.2%85.5K after10b5-1
Mar 3, 2026 (view filing)Mar 21 daySandercock BrettChief Financial OfficerSSaleResMed Common Stock−1.00K$254.30−$254.3K−1.2%84.5K after10b5-1
Apr 3, 2026 (view filing)Apr 12 daysSandercock BrettChief Financial OfficerSSaleResMed Common Stock−1.00K$224.31−$224.3K−1.2%83.5K after10b5-1